Comment
doi: 10.1002/pbc.26059.
Epub 2016 May 17.
Hydroxyurea and Pain History in Relation to Patient-Reported Outcomes Using PROMIS Measures and the Frequency of Assessments in Sickle Cell Disease Patients
Affiliations
- PMID: 27187560
- DOI: 10.1002/pbc.26059
Item in Clipboard
Comment
Hydroxyurea and Pain History in Relation to Patient-Reported Outcomes Using PROMIS Measures and the Frequency of Assessments in Sickle Cell Disease Patients
Pediatr Blood Cancer.
2017 Jan.
No abstract available
Comment in
-
Reply to comment on: Hydroxyurea and pain history in relation to patient-reported outcomes using PROMIS® measures and the frequency of assessments in sickle cell disease patients.Pediatr Blood Cancer. 2017 Jan;64(1):204. doi: 10.1002/pbc.26095. Epub 2016 Sep 8. Pediatr Blood Cancer. 2017. PMID: 27605162 No abstract available.
Comment on
-
Responsiveness of PROMIS® Pediatric Measures to Hospitalizations for Sickle Pain and Subsequent Recovery.Pediatr Blood Cancer. 2016 Jun;63(6):1038-45. doi: 10.1002/pbc.25931. Epub 2016 Feb 8. Pediatr Blood Cancer. 2016. PMID: 26853841 Free PMC article.
-
Initial Evaluation of the Pediatric PROMIS® Health Domains in Children and Adolescents With Sickle Cell Disease.Pediatr Blood Cancer. 2016 Jun;63(6):1031-7. doi: 10.1002/pbc.25944. Epub 2016 Feb 19. Pediatr Blood Cancer. 2016. PMID: 26895143 Free PMC article.
Similar articles
-
Reply to comment on: Hydroxyurea and pain history in relation to patient-reported outcomes using PROMIS® measures and the frequency of assessments in sickle cell disease patients.Pediatr Blood Cancer. 2017 Jan;64(1):204. doi: 10.1002/pbc.26095. Epub 2016 Sep 8. Pediatr Blood Cancer. 2017. PMID: 27605162 No abstract available.
-
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.N Engl J Med. 2018 Jul 19;379(3):226-235. doi: 10.1056/NEJMoa1715971. N Engl J Med. 2018. PMID: 30021096 Clinical Trial.
-
Hydroxyurea: Clinical and Hematological Effects in Patients With Sickle Cell Anemia.Glob J Health Sci. 2015 Aug 19;8(3):252-6. doi: 10.5539/gjhs.v8n3p252. Glob J Health Sci. 2015. PMID: 26493428 Free PMC article.
-
Hydroxyurea in the treatment of sickle-cell anemia.Ann Pharmacother. 1997 Nov;31(11):1393-6. Ann Pharmacother. 1997. PMID: 9391697 Review.
-
Hydroxyurea therapy: improving the lives of patients with sickle cell disease.Pediatr Nurs. 2006 Nov-Dec;32(6):541-3. Pediatr Nurs. 2006. PMID: 17256291 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
